• US & International Statistics about Amphetamine Use

    Amphetamine is defined by the National Drug and Alcohol Research Center as a term that refers to a whole family of synthetic drugs that are all chemically related to amphetamine and all have pretty similar effects. It was first synthesized in 1887 in Germany, but it wasn’t until the 1920s when it was marketed to treat various illnesses like obesity and ADHD.

    Among its short-term effects include euphoria, talkativeness, reduction of appetite, dry mouth, and nausea. On the other hand, extreme mood swings, paranoia, panic attacks, seizures, hallucination, and uncontrolled violent reactions are some of the most visible long-term effects that amphetamine users are expected to experience.

    Amphetamine Urine Drug Test Kit

    Amphetamine Urine Drug Test Kit

    When amphetamines were severely abused by young people and illegal speed labs sprung between 1960s and 1970s, the federal government of the United States began to crack down illegal manufacturers of the drug and started to pass on laws that would regulate the distribution and manufacturing of amphetamine-type stimulants. Two of the strictly implemented laws are the Controlled Substances Act of 1970 and the Federal Domestic Chemical Diversion Act of 1993.

    In the passing of times, amphetamines refused to die down and many people continue to abuse and misuse the drug. In the 2003 Ecstasy and Amphetamines Global Survey released by the United Nations Office On Drugs and Crime, amphetamine-type stimulants are divided into two major sub-groups:

    • AMPHETATIMES (amphetamine and methamphetamine) and

    Meanwhile, a recently released comprehensive report titled World Drug Report 2010 by the United Nations Office On Drugs and Crime estimated that between 13.7 and 52.9 million people used amphetamine-group substances at least once in the preceding year, with a corresponding annual prevalence range of 0.3% to 1.2% of the population aged 15 to 64.

    The World Drug Report 2010 noted that in Asia, between 4.4 and 37.9 million people are estimated to have used amphetamines-group substances in the past year. Based on the 2008 UNODC annual reports questionnaire (ARQ) reported by the 13 out of 29 member states of Asia, there has been some increase in the use of amphetamine-type stimulants among their respective population.

    Bangladesh, China (including Hong Kong), Indonesia, Japan, Mongolia, Myanmar, Thailand, and Vietnam were the countries that reported an increase in amphetamine-group substance use over the past year.

    Recent data showed the Philippines, Thailand, and Laos have the highest annual prevalence use of amphetamines-group substances in East and South-East Asia.

    In Europe, between 2.5 million and 3.2 million people aged 15-64 had used amphetamines-group substances at least once in the past year. The World Drug Report 2010 further documented that there have been high prevalence rates reported for South-East European countries such as: Bosnia and Herzegovina (1%), Montenegro (0.5%), and Serbia (0.2%).

    Meanwhile, the Czech Republic, Denmark, the United Kingdom, Norway and Estonia remain as countries with higher than average annual prevalence of amphetamine-group substance use.

    In Africa, the use of amphetamine-group substances rose during the past year is between 1.5 million and 5.2 million compared to 1.4 million – 4 million people estimated in 2007.

    According to the World Drug Report 2010, though amphetamine-groups substance use remain high in North America, a recent survey showed a decline in the use of amphetamines. Among the population aged 12 years and older, the annual prevalence of all stimulants use was reported as 1.5% in 2006, 1.2% in 2007, and 1.1% in 2008.

    Meanwhile, Canada has registered an increase in the use of amphetamine-group stimulants between 2004 and 2008. The annual prevalence of amphetamine-group stimulants reported in 2008 is 1.5% among the population aged 15-64, compared to 1% in 2004.

    Though there has been signs of decline in recent years, the prevalence of amphetamines use in New Zealand and Australia remains one of the highest in the world. Based on the World Drug Report 2010, New Zealand registered 2.1% annual prevalence among the population aged 16-64 in 2008, whereas, Australia registered 2.7% annual prevalence among the population aged 16-64 in 2007.







    Categories: Amphetamine

    Tags: , , ,

    Leave a Reply

    Your email address will not be published. Required fields are marked *